7-(2-((2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione hydrochloride

Catalog No. :
ACJBVF942
CAS No. :
2572-61-4
Molecular Formula :
C17H22ClN5O5
Molecular Weight :
411.85

IUPAC Name:7-(2-((2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione hydrochloride

7-(2-((2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-(2-((2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione hydrochloride
IUPAC Name7-(2-((2-(3,4-dihydroxyphenyl)-2-hydroxyethyl)amino)ethyl)-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione hydrochloride
Molecular FormulaC17H22ClN5O5
Molecular Weight411.85
SMILESCN1C(=O)C2=C(N=CN2CCNCC(O)C2=CC(O)=C(O)C=C2)N(C)C1=O.Cl
InChI KeyCSKCJAUXLOQTMM-UHFFFAOYSA-N
Synonym7-[2-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]ethyl]-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrochloride;7-[2-[[2-(3,4-Dihydrophenyl)-2-hydroxyethyl]amino]ethyl]-3,7-dihydro-1,3-dimethyl-H-purin-2,6-dionmonohydrochlorid;Nsc293888;Theodrenaline hydrochloride
CAS No.2572-61-4

Synthetic Route by SureRoute

1. ACJBVF942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJBVF942 route product structure diagram
    ACJBVF9422572-61-4
Inquiry

2. ACJBVF942 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACZUCY679 route compound structure diagram
    ACZUCY6795878-61-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJBVF942 route product structure diagram
    ACJBVF9422572-61-4
Inquiry

Comments (0)